New Pill Successfully Lowers Lp(a) Levels
Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk and for which no approved therapies currently exist.
Related Articles
Welcome! You are invited to join a webinar: AHA Centennial Webinar – Hypertension Treatment Trials: Past, Present and Future. After registering, you will receive a confirmation email about joining the webinar.
The Hypertension Education Editors, in conjunction with the AHA Council on Hypertension SCILL committee, present a webinar in the journal’s #HypEdSeries: AHA Centennial Webinar –…
Home | Art By Dean
“Explore ‘Art By Dean’ – a collection of fine art showcasing a lifetime of creative passion and artistic excellence. Discover unique artworks and inspiring pieces.
Welcome! You are invited to join a webinar: AHA Centennial Webinar – Hypertension Treatment Trials: Past, Present and Future. After registering, you will receive a confirmation email about joining the webinar.
The Hypertension Education Editors, in conjunction with the AHA Council on Hypertension SCILL committee, present a webinar in the journal’s #HypEdSeries: AHA Centennial Webinar –…
Association of Systemic Inflammatory Response Syndrome With Cardiovascular Events After Mitral Transcatheter Edge‐to‐Edge Repair | Journal of the American Heart Association
BackgroundSystemic inflammatory response syndrome (SIRS) following cardiovascular interventions is associated with adverse events during hospitalization and follow‐up. Mitral transcatheter edge‐to‐…
MONTHLY WEBINAR SERIES | EVENT – SEPTEMBER 2024 | Dr Chadi Alraies
Monthly webinar series repost ; In this episode we dived into the “Invasive Imaging for Structural Heart Intervention” This session was led by the renowned…
Cardiovascular magnetic resonance imaging in mitral valve disease
Abstract. This paper describes the role of cardiovascular magnetic resonance (CMR) imaging in assessing patients with mitral valve disease. Mitral regurgit
JACC: CardioOncology Expert Panel Addresses CV Care Before Cancer Treatment – American College of Cardiology
An expert panel report, one of three in a special series published in JACC: CardioOncology, provides a review of the current evidence for the cardiovascular…
Transfusion in Acute Brain Injury: Is Less Still More?
Whether a restrictive or liberal transfusion strategy offers the best outcomes after acute brain injury has been the subject of ongoing debate. Will publication of…
Graduate Medical Education, 2023-2024
This Appendix presents 2023 National GME Census data detailing the numbers and types of ACGME-accredited training programs and the residents and fellows in them.
Contemporary Outcomes of TAVR Using a Balloon-Expandable Valve in Patients With Severe Mitral Stenosis: Insights From the Transcatheter Valve Therapies Registry | Circulation: Cardiovascular Interventions
BACKGROUND: While initial data for transcatheter aortic valve replacement (TAVR) in aortic stenosis patients with mitral stenosis (MS) suggested a poor short-term prognosis, outcomes for…
